Cell and Gene Therapy Industry Faces 'Crucial' Phase Following Marks' Departure from FDA

Cell and Gene Therapy Industry Faces ‘Crucial’ Phase Following Marks’ Departure from FDA

Cell and Gene Therapy Industry Faces 'Crucial' Phase Following Marks' Departure from FDA